Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures Glaukos GKOS Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares ACRS Q1 2026 Earnings Narrower Net Loss Beats Expectations as Cost Management Continues FCF Q1 2026 Earnings EPS Misses Estimates Stock Slides Slightly IPAR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher FMC Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment